Cargando…

Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma

OBJECTIVE: Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare type of primary liver cancer with characteristics of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). The pathogenesis of cHCC- CC is poorly understood due to a shortage of suitable in vitro models. Due to scar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Hyo-Suk, Ryu, Jae-Sung, Lee, Jaeseo, Mun, Seon Ju, Hong, Yeon-Hwa, Shin, Yongbo, Chung, Kyung-Sook, Son, Myung Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royan Institute 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035233/ https://www.ncbi.nlm.nih.gov/pubmed/35451583 http://dx.doi.org/10.22074/cellj.2022.7765

Ejemplares similares

Long-Term Expansion of Functional Human Pluripotent Stem Cell-Derived Hepatic Organoids
por: Mun, Seon Ju, et al.
Publicado: (2020)

Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids
por: Mun, Seon Ju, et al.
Publicado: (2021)

Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model
por: Ryu, Jae-Sung, et al.
Publicado: (2019)

Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma
por: Ying, Fan, et al.
Publicado: (2023)

Quantitative proteomic analysis of bile in extrahepatic cholangiocarcinoma patients
por: Son, Kuk Hui, et al.
Publicado: (2020)

Adrenal metastasis in sequentially developed combined hepatocellular carcinoma-cholangiocarcinoma: A case report
por: Nugroho, Adianto, et al.
Publicado: (2018)

Ideal sphere-forming culture conditions to maintain pluripotency in a hepatocellular carcinoma cell lines
por: Min, Seon Ok, et al.
Publicado: (2015)

Induced Pluripotent Stem Cell Lines Derived from Equine Fibroblasts
por: Nagy, Kristina, et al.
Publicado: (2011)

Generation and characterization of integration-free induced pluripotent stem cells from patients with autoimmune disease
por: Son, Mi-Young, et al.
Publicado: (2016)

Integrative analysis of single-cell RNA-seq and ATAC-seq reveals heterogeneity of induced pluripotent stem cell-derived hepatic organoids
por: Kim, Jong-Hwan, et al.
Publicado: (2023)

Optimized Approaches for the Induction of Putative Canine Induced Pluripotent Stem Cells from Old Fibroblasts Using Synthetic RNAs
por: Kim, Mirae, et al.
Publicado: (2020)

Upregulation of mitochondrial NAD(+) levels impairs the clonogenicity of SSEA1(+) glioblastoma tumor-initiating cells
por: Son, Myung Jin, et al.
Publicado: (2017)

Erratum to: Induced Pluripotent Stem Cell Lines Derived from Equine Fibroblasts
por: Nagy, Kristina, et al.
Publicado: (2011)

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma
por: Noh, Sang Jae, et al.
Publicado: (2012)

Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma
por: Wang, Tao, et al.
Publicado: (2020)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Yang, Jie, et al.
Publicado: (2020)

Breast Metastasis From a Combined Hepatocellular–Cholangiocarcinoma
por: Silva, Marco, et al.
Publicado: (2019)

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection
por: Na, Seong Kyun, et al.
Publicado: (2018)

Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts
por: Park, Jihwan, et al.
Publicado: (2017)

Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Nomogram Based on Ultrasonographic Features and Clinical Indicators
por: Chen, Yanling, et al.
Publicado: (2022)

Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center
por: Penzkofer, Lea, et al.
Publicado: (2023)

Treatment of Combined Hepatocellular and Cholangiocarcinoma
por: Leoni, Simona, et al.
Publicado: (2020)

Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma
por: Alonso-Peña, Marta, et al.
Publicado: (2019)

Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma
por: Murugesan, Karthikeyan, et al.
Publicado: (2021)

A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model
por: Lee, Eung Suk, et al.
Publicado: (2012)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
por: Auer, Timo Alexander, et al.
Publicado: (2023)

Differentiation of Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma through MRI Radiomics
por: Liu, Ning, et al.
Publicado: (2023)

Establishment of a pancreatic stem cell line from fibroblast-derived induced pluripotent stem cells
por: Kuise, Takashi, et al.
Publicado: (2014)

Derivation of induced pluripotent stem cells from orangutan skin fibroblasts
por: Ramaswamy, Krishna, et al.
Publicado: (2015)

In Vitro Induction of Pluripotency from Equine Fibroblasts in 20% or 5% Oxygen
por: de Castro, Raquel V. G., et al.
Publicado: (2020)

Pluripotency-independent induction of human trophoblast stem cells from fibroblasts
por: Naama, Moriyah, et al.
Publicado: (2023)

ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma
por: Park, Kyun Woo, et al.
Publicado: (2013)

Immortalized murine fibroblast cell lines are refractory to reprogramming to pluripotent state
por: Skvortsova, Elena V., et al.
Publicado: (2018)

Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver
por: Wang, Jue, et al.
Publicado: (2010)

Current update on combined hepatocellular-cholangiocarcinoma
por: Maximin, Suresh, et al.
Publicado: (2014)

Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Massarweh, Nader N., et al.
Publicado: (2017)

Combined hepatocellular-cholangiocarcinoma in a cow
por: HONDA, Hidetsugu, et al.
Publicado: (2019)

Clinicopathological Characteristics in Combined Hepatocellular-Cholangiocarcinoma: A Single Center Study in Korea
por: Park, Hana, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7stuthf0fnos10f4n950kapa3k